Sector Alpha Week of 2026-08-14
Sector Alpha — machine-written from the numbers · Data as of 2026-08-14

India Cements Ltd

INDIACEM
Cement

India Cements Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the P/E sits at the 83rd percentile of its own range — the multiple has already done part of the work.

The price is in a downtrend (1 weeks in) while the P/E sits at the 83rd percentile of its own 10-year range. Underneath, the last four quarters read mixed, and 539% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Price
₹375
+1.7% 1Y
P/E
86.2×
83rd pctile
of its own 10-year range
Revenue (Jun 26)
₹1,019 Cr
−0.6% YoY
Profit (Jun 26)
₹27.0 Cr
Operating margin
15.0%
+7.0 pp YoY
ROCE
1%
FY26
ROIC
1.3%
vs WACC 12.0% → −10.7 pp
Cash conversion
539%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

India Cements Ltd trades at ₹375, in a downtrend and 1 weeks into that stage. That is −4.1% against its own 200-day average. It sits at 17% of a 52-week range of ₹354 to ₹479. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (2 weeks and counting).

Today the stock is in a downtrend — week 1 of stage 4, confirmed. At ₹375 it trades −4.1% versus its 200-day average and sits at 17% of its 52-week range (₹354–₹479).

Aug 26: ₹375 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−4.1% versus the 200-day line, week 1 of stage 4
Price50-day avg200-day avg
S2S4S2S4S2S1₹500₹421₹342₹262₹183₹375₹391Aug 23May 24Feb 25Nov 25Aug 26
S2S4S2S4S2S1₹500₹421₹342₹262₹183₹375₹391Aug 23Feb 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (550 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Feb 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +456% while the NIFTY 500 moved +284% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (2 weeks and counting; last ahead the week of 2026-07-31) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

India Cements Ltd trades at 86.2× P/E, at the pricey end of its own range (83rd percentile). Its long-run median P/E is 41.9×, measured across 10.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 86.2× is at the pricey end of its own range (83rd percentile), against a long-run median of 41.9× measured over 10.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 86.2× vs a 41.9× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.0-year window; loss-period spikes above 126× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (83rd percentile)
P/EMedianEPS (TTM) (quarterly)
134.2×₹8.0103.3×₹6.072.4×₹4.041.5×₹2.010.6×₹0.0×86.10×₹4Aug 16Mar 18Dec 19Jul 21Aug 26
134.2×₹8.0103.3×₹6.072.4×₹4.041.5×₹2.010.6×₹0.0×86.10×₹4Aug 16Dec 19Aug 26
PEG 0.66 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
1.0×0.9×0.8×0.7×0.6××0.66×Q2 FY22Q2 FY23Q3 FY24Q4 FY25Q1 FY27
1.0×0.9×0.8×0.7×0.6××0.66×Q2 FY22Q3 FY24Q1 FY27
P/E
86.2×
83rd percentile of 10y
PEG
n/m
not derivable — 3-year earnings growth unavailable

The price move, decomposed: over 5y, of the +16.2%/yr price move, ~−10.1%/yr came from earnings growth and ~+26.3 pp from the multiple (expanding); over 10y, of the +11.9%/yr price move, ~+1.2%/yr came from earnings growth and ~+10.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

India Cements Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +8.3% in FY26 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
18%345%8.6%182%−0.9%19%−10%−144%−20%−307%%%8.3%−243.7%FY16FY21FY26
18%345%8.6%182%−0.9%19%−10%−144%−20%−307%%%8.3%−243.7%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating
RevenueProfitEPS
9.3%348%1.3%174%−6.6%0.0%−15%−174%−22%−348%%%7%233.3%−300%Sep 23Dec 24Jun 26
9.3%348%1.3%174%−6.6%0.0%−15%−174%−22%−348%%%7%233.3%−300%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
2.5%1.8%1.0%0.2%−0.5%%1.7%Sep 23Mar 24Dec 24Sep 25Jun 26
2.5%1.8%1.0%0.2%−0.5%%1.7%Sep 23Dec 24Jun 26
Revenue growth
Flat
latest +7.0% · span −20.3% to +7.1%
ROCE
Stuck low
latest 1.7% · span −0.3%–2.3%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+8.3%−7.2%−0.1%−0.8%
Share price+1.7%+14.1%+16.2%+11.9%
Revenue YoY (Jun 26)
−0.6%
latest quarter vs a year ago
Revenue 10y
−0.8%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

44.8/100 — rank 15 of 26 in Cement · 75% evidence confidence

India Cements Ltd scores 44.8 out of 100 against the 26 companies it is compared with in Cement, ranking 15. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 21 + 3.7 + 5.9 + 14.2 = 44.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

India Cements Ltd reported ₹1,019 Cr of revenue in the Jun 26 quarter, −0.6% year on year. Over 10 years it has compounded at −0.8% a year. The last full year, FY26, came in at ₹4,485 Cr. The last four reported quarters add to ₹4,479 Cr.

FY26 revenue came in at ₹4,485 Cr (+8.3% on the year), capping 10 years at −0.8% compound. The latest quarter (Jun 26) printed ₹1,019 Cr, −0.6% year on year.

FY26 revenue ₹4,485 Cr (+8.3% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
−0.8% a year over 10 years
RevenueYoY growth
6.2k18%4.7k8.6%3.1k−0.9%1.6k−10%0−20%₹ Cr%₹4,4858.3%FY16FY21FY26
6.2k18%4.7k8.6%3.1k−0.9%1.6k−10%0−20%₹ Cr%₹4,4858.3%FY16FY21FY26
Jun 26: ₹1,019 Cr (−0.6% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
1.4k22%1.0k8.6%683−5.0%341−19%0−32%₹ Cr%₹1,019−0.6%Sep 23Dec 24Jun 26
1.4k22%1.0k8.6%683−5.0%341−19%0−32%₹ Cr%₹1,019−0.6%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +7.5% growth against the decade's −0.8% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +7.0% over the last 4 quarters against −1.8%/yr over the last 8 — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

India Cements Ltd's operating margin is 15.0% in the Jun 26 quarter, +7.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −8.0% to 18.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 15.0%, +7.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −8.0%–18.0%.

Why the margin moved: operating margin went +7.2 pp year on year while gross margin went −12.0 pp — the gain came mostly from the gross line: input costs and pricing.

FY26: 9.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −8.0–18.0% band over 13 years
operating marginYoY change (pp)
20%19%13%11%5.0%2.3%−2.5%−6.3%−10%−15%%%9%17%FY14FY20FY26
20%19%13%11%5.0%2.3%−2.5%−6.3%−10%−15%%%9%17%FY14FY20FY26
Jun 26: 15.0% operating margin (+7.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
18%31%7.7%16%−2.5%1.4%−13%−13%−23%−28%%%15%7%Sep 23Dec 24Jun 26
18%31%7.7%16%−2.5%1.4%−13%−13%−23%−28%%%15%7%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

India Cements Ltd earned ₹27.0 Cr of net profit in the Jun 26 quarter. The full FY26 year was a loss of ₹67.0 Cr. That is 2.6% of the quarter's revenue. The same quarter a year earlier lost ₹133 Cr. 5 of the last 12 reported quarters were loss-making.

Jun 26 profit was ₹27.0 Cr, null year on year. On the full year, FY26 printed ₹−67.0 Cr (null).

FY26 profit ₹−67.0 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
244354%117194%−933%−135−127%−262−288%₹ Cr%₹−67−243.7%FY16FY21FY26
244354%117194%−933%−135−127%−262−288%₹ Cr%₹−67−243.7%FY16FY21FY26
Jun 26: ₹27.0 Cr (null YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
15612,770%239,253%−1105,735%−2432,218%−376−1,300%₹ Cr%₹27233.3%Sep 23Dec 24Jun 26
15612,770%239,253%−1105,735%−2432,218%−376−1,300%₹ Cr%₹27233.3%Sep 23Dec 24Jun 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 539% of India Cements Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−27.0 Cr of operating cash against ₹−67.0 Cr of profit. After ₹15.0 Cr of capital spending, ₹−42.0 Cr was left as free cash.

FY26: operating cash of ₹−27.0 Cr against reported profit of ₹−67.0 Cr, leaving free cash of ₹−42.0 Cr after ₹15.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 539% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹−27.0 Cr vs profit ₹−67.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY25 reflects an acquisition year — point shown clipped.
539% of 3-year profit arrived as cash
Operating cashNet profitFree cash
1.3k361−586−1.5k−2.5k₹ Cr₹−27₹−67₹−42FY16FY21FY26
1.3k361−586−1.5k−2.5k₹ Cr₹−27₹−67₹−42FY16FY21FY26
FY26: CFO = 505% of profit (three-year rate 539%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
316%258%200%142%84%%300%FY16FY21FY26
316%258%200%142%84%%300%FY16FY21FY26

Why conversion sits at 539%: the cash cycle stretched 145 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 6.8× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

India Cements Ltd's cash conversion cycle runs −28 days in FY26, up from −173 days in FY21. Capital spending ran ₹5,173 Cr over the last 3 years. At FY26 sales of ₹4,485 Cr each day of that cycle holds about ₹12.3 Cr, so roughly ₹−344 Cr sits inside the business at any moment.

FY26: debtors at 20 days, inventory at 269 days — roughly 8.8 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −28 days, looser than FY21's −173.

The full loop: cash goes out to suppliers and production on day 0; stock waits 269 days to sell; customers pay about 20 days after that; and suppliers themselves are paid at 318 days — netting out to the −28-day cycle.

In money terms: at FY26 sales of ₹4,485 Cr, each day of the cycle holds about ₹12.3 Cr — so the −28-day loop keeps roughly ₹−344 Cr sitting inside the business at any moment.

FY26: a −28-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+145 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
624409194−22−237days−28d269d20d318dFY14FY17FY20FY23FY26
624409194−22−237days−28d269d20d318dFY14FY20FY26

On the investment side: capital spending of ₹5,173 Cr over the last 3 fiscal years against ₹758 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹344 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹15.0 Cr, work-in-progress ₹344 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
5.4k3.9k2.4k928−563₹ Cr₹15₹344FY16FY18FY21FY23FY26
5.4k3.9k2.4k928−563₹ Cr₹15₹344FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

India Cements Ltd earns a ROCE of 1% in FY26. That is up from a trough of −5% in FY25. Return on invested capital clears the cost of that capital by −10.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −1.5% net margin on 0.33× asset turns.

FY26 ROCE is 1%, recovered from a FY25 trough of −5% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): −1.5% net margin × 0.33× asset turns × 1.32× balance-sheet leverage ≈ −0.7% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 1.3% − 12.0% = a −10.7 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 1% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY25's −5%
ROCEROIC (annual)WACC
13%8.2%3.0%−2.2%−7.4%%1%0.9%FY14FY20FY26
13%8.2%3.0%−2.2%−7.4%%1%0.9%FY14FY20FY26
Q4 FY26: ROCE 0.8% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
14%8.0%2.4%−3.2%−8.7%%0.8%0.8%Q1 FY24Q3 FY25Q1 FY27
14%8.0%2.4%−3.2%−8.7%%0.8%0.8%Q1 FY24Q3 FY25Q1 FY27
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

India Cements Ltd carries total debt of ₹1,305 Cr against shareholder equity of ₹10,124 Cr as of Jun 26, a debt-to-equity of 0.13 — effectively unlevered. On the annual view that ratio went from 0.51 in FY22 to 0.13 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of ₹1,305 Cr against shareholder equity of ₹10,124 Cr — a debt-to-equity of 0.13. On the annual view, debt-to-equity went from 0.51 (FY22) to 0.13 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹1,305 Cr at 0.13× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
3.3k0.5×2.5k0.4×1.7k0.3×8350.2×00.1×₹ Cr×₹1,3050.13×FY22FY24FY26
3.3k0.5×2.5k0.4×1.7k0.3×8350.2×00.1×₹ Cr×₹1,3050.13×FY22FY24FY26
Jun 26: debt ₹1,305 Cr, debt-to-equity 0.13 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
3.1k0.5×2.3k0.4×1.5k0.3×7650.2×00.1×₹ Cr×₹1,3050.13×Sep 23Dec 24Jun 26
3.1k0.5×2.3k0.4×1.5k0.3×7650.2×00.1×₹ Cr×₹1,3050.13×Sep 23Dec 24Jun 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Promoters added 46.6 points of India Cements Ltd over 8 quarters, the biggest move on the register. That takes promoters to 75.0% of the company. Foreign institutions moved −14.2 points over the same window, to 3.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: +46.6 points over 8 quarters to 75.0%; Foreign institutions: −14.2 points over 8 quarters to 3.4%; Domestic institutions: +6.8 points over 8 quarters to 12.6%.

Why the register moved: rotation — foreign institutions −14.2 points against domestic institutions +6.8 points over 8 quarters, with promoters +46.6 points — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.

Fiscal-year ends: promoters +46.6 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
88%65%42%20%−2.8%%75%3.5%12.9%8.6%Mar 24Mar 25Mar 26
88%65%42%20%−2.8%%75%3.5%12.9%8.6%Mar 24Mar 25Mar 26
Promoters added 46.6 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
88%65%42%19%−3.3%%75%3.4%12.6%9%Jun 23Dec 24Jun 26
88%65%42%19%−3.3%%75%3.4%12.6%9%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

India Cements Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Cement
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Rain Industries LtdRAIN 69.8/100Favorable setup75% evidence LEADER 28.4/35 Revenue 17% · PAT 100% · OPM change 5 pp 95% evidence 10.5/25 ROCE 8.3% · OPM 19% 76% evidence 10.9/20 P/E 13.1× · PEG — 15% evidence 20.0/20 RS sector 50.4% · RS bench 37.5% · 1Y 30.2%12 of 12 weeks ahead 100% evidence
Exact sum: 28.4 + 10.5 + 10.9 + 20 = 69.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Star Cement LtdSTARCEMENT 69.4/100Favorable setup94% evidence ASLEEP 25.6/35 Revenue 14.5% · PAT 55.1% · OPM change -4 pp 100% evidence 20.2/25 ROCE 16.7% · OPM 21% 100% evidence 11.4/20 P/E 21.4× · PEG 1.11 100% evidence 12.2/20 RS sector 13.8% · RS bench -13.7% · 1Y -23%0 of 10 weeks ahead 70% evidence
Exact sum: 25.6 + 20.2 + 11.4 + 12.2 = 69.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3UltraTech Cement LtdULTRACEMCO 64.1/100Mixed-positive evidence76% evidence ASLEEP 23.2/35 Revenue 17.2% · PAT 26.7% · OPM change -1 pp 95% evidence 17.1/25 ROCE 12.7% · OPM 20% 76% evidence 9.5/20 P/E 39.7× · PEG — 50% evidence 14.3/20 RS sector 17% · RS bench -4.1% · 1Y -4.4%0 of 10 weeks ahead 70% evidence
Exact sum: 23.2 + 17.1 + 9.5 + 14.3 = 64.1 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
4NCL Industries LtdNCLIND 60.9/100Mixed-positive evidence87% evidence ASLEEP 23.2/35 Revenue 3.7% · PAT 100% · OPM change -3 pp 95% evidence 18.1/25 ROCE 14.5% · OPM 12% 95% evidence 9.4/20 P/E 6.3× · PEG — 50% evidence 10.2/20 RS sector -1.7% · RS bench -11% · 1Y -17.3%2 of 12 weeks ahead 100% evidence
Exact sum: 23.2 + 18.1 + 9.4 + 10.2 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Orient Cement LtdORIENTCEM 58.6/100Mixed-positive evidence93% evidence ASLEEP 17.9/35 Revenue -12.1% · PAT -19.3% · OPM change 3 pp 100% evidence 16.9/25 ROCE 16.5% · OPM 24% 100% evidence 16.1/20 P/E 12.8× · PEG 0.25 65% evidence 7.7/20 RS sector -12.1% · RS bench -21.1% · 1Y -43.1%0 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 16.9 + 16.1 + 7.7 = 58.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Mangalam Cement LtdMANGLMCEM 58.5/100Mixed-positive evidence100% evidence FADING 18.1/35 Revenue 0.5% · PAT 90% · OPM change -5 pp 100% evidence 10.6/25 ROCE 11% · OPM 12% 100% evidence 16.0/20 P/E 19× · PEG 0.6 100% evidence 13.8/20 RS sector 17% · RS bench 6.9% · 1Y 23%4 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 10.6 + 16 + 13.8 = 58.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7HeidelbergCement India LtdHEIDELBERG 56.6/100Mixed-positive evidence100% evidence BASING 15.7/35 Revenue 6.6% · PAT 2.6% · OPM change -4 pp 100% evidence 14.9/25 ROCE 14.7% · OPM 11% 100% evidence 13.7/20 P/E 29.5× · PEG 0.82 100% evidence 12.3/20 RS sector 0.3% · RS bench -9.4% · 1Y -24.7%0 of 12 weeks ahead 100% evidence
Exact sum: 15.7 + 14.9 + 13.7 + 12.3 = 56.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
8Dalmia Bharat LtdDALBHARAT 55.5/100Mixed-positive evidence94% evidence TURNING 14.3/35 Revenue 7.6% · PAT 0.4% · OPM change -3 pp 100% evidence 13.2/25 ROCE 7.6% · OPM 21% 100% evidence 15.4/20 P/E 31.4× · PEG 0.72 100% evidence 12.6/20 RS sector 12.6% · RS bench -9.5% · 1Y -17.9%0 of 10 weeks ahead 70% evidence
Exact sum: 14.3 + 13.2 + 15.4 + 12.6 = 55.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
9JSW Cement LtdJSWCEMENT 52.4/100Thin evidence · provisional52% evidence FADING 19.2/35 Revenue 15.6% · PAT 100% · OPM change -5 pp 71% evidence 11.8/25 ROCE 11.1% · OPM 16% 76% evidence 10.2/20 P/E 22.5× · PEG — 15% evidence 11.2/20 RS sector — · RS bench -0.9% · 1Y -11%3 of 10 weeks ahead 25% evidence
Exact sum: 19.2 + 11.8 + 10.2 + 11.2 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Shree Cement LtdSHREECEM 50.3/100Mixed-positive evidence97% evidence ASLEEP 15.8/35 Revenue 12.6% · PAT 9.9% · OPM change -5 pp 95% evidence 13.3/25 ROCE 10.3% · OPM 20% 95% evidence 9.7/20 P/E 54.9× · PEG 0.96 100% evidence 11.5/20 RS sector 1.5% · RS bench -8.1% · 1Y -18.5%3 of 12 weeks ahead 100% evidence
Exact sum: 15.8 + 13.3 + 9.7 + 11.5 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11J K Cements LtdJKCEMENT 49.4/100Mixed-negative evidence94% evidence ASLEEP 12.1/35 Revenue 15.9% · PAT -7.1% · OPM change -5 pp 100% evidence 16.7/25 ROCE 15.1% · OPM 16% 100% evidence 8.2/20 P/E 42× · PEG 1.46 100% evidence 12.4/20 RS sector 10.4% · RS bench -8.8% · 1Y -24.7%0 of 10 weeks ahead 70% evidence
Exact sum: 12.1 + 16.7 + 8.2 + 12.4 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Nuvoco Vistas Corporation LtdNUVOCO 49.3/100Mixed-negative evidence87% evidence ASLEEP 22.1/35 Revenue 9.5% · PAT 100% · OPM change 0 pp 100% evidence 10.2/25 ROCE 7% · OPM 18% 100% evidence 4.9/20 P/E 28.5× · PEG 8.14 65% evidence 12.1/20 RS sector 3.6% · RS bench -8% · 1Y -24.7%4 of 10 weeks ahead 70% evidence
Exact sum: 22.1 + 10.2 + 4.9 + 12.1 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Prism Johnson LtdPRSMJOHNSN 45.8/100Mixed-negative evidence61% evidence ASLEEP 18.1/35 Revenue 4.8% · PAT 100% · OPM change 2 pp 71% evidence 7.0/25 ROCE 5.9% · OPM 12% 76% evidence 9.2/20 P/E 45.1× · PEG — 15% evidence 11.5/20 RS sector 14.3% · RS bench -21.4% · 1Y -28.1%0 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 7 + 9.2 + 11.5 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14JK Lakshmi Cement LtdJKLAKSHMI 45.0/100Mixed-negative evidence69% evidence ASLEEP 14.7/35 Revenue 8.7% · PAT 0.5% · OPM change -4 pp 95% evidence 14.1/25 ROCE 12% · OPM 14% 76% evidence 10.7/20 P/E 17.7× · PEG — 15% evidence 5.5/20 RS sector -8.2% · RS bench -24.7% · 1Y -39.3%0 of 10 weeks ahead 70% evidence
Exact sum: 14.7 + 14.1 + 10.7 + 5.5 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15India Cements Ltdthis pageINDIACEM 44.8/100Mixed-negative evidence75% evidence ASLEEP 21.0/35 Revenue 7% · PAT 100% · OPM change 7 pp 74% evidence 3.7/25 ROCE 1.2% · OPM 15% 100% evidence 5.9/20 P/E 86.2× · PEG — 50% evidence 14.2/20 RS sector 20% · RS bench -8.2% · 1Y 5.7%0 of 10 weeks ahead 70% evidence
Exact sum: 21 + 3.7 + 5.9 + 14.2 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Birla Corporation LtdBIRLACORPN 43.5/100Mixed-negative evidence94% evidence ASLEEP 18.6/35 Revenue 3.9% · PAT 44.6% · OPM change -1 pp 100% evidence 11.0/25 ROCE 9.8% · OPM 13% 100% evidence 9.1/20 P/E 12.5× · PEG 3.92 100% evidence 4.8/20 RS sector -14% · RS bench -15.3% · 1Y -27.6%3 of 9 weeks ahead 70% evidence
Exact sum: 18.6 + 11 + 9.1 + 4.8 = 43.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17ACC LtdACC 43.2/100Mixed-negative evidence94% evidence ASLEEP 9.7/35 Revenue 11.6% · PAT -21.1% · OPM change -5 pp 100% evidence 9.9/25 ROCE 11.2% · OPM 8% 100% evidence 17.0/20 P/E 13.1× · PEG 0.92 100% evidence 6.6/20 RS sector -6.7% · RS bench -18.5% · 1Y -26.1%0 of 10 weeks ahead 70% evidence
Exact sum: 9.7 + 9.9 + 17 + 6.6 = 43.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
18K C P LtdKCP 41.8/100Mixed-negative evidence81% evidence ASLEEP 8.0/35 Revenue 6.5% · PAT -17.1% · OPM change -8 pp 95% evidence 14.3/25 ROCE 12.2% · OPM 8% 95% evidence 14.2/20 P/E 11.4× · PEG — 50% evidence 5.3/20 RS sector -14% · RS bench -12% · 1Y -21.3%3 of 11 weeks ahead 70% evidence
Exact sum: 8 + 14.3 + 14.2 + 5.3 = 41.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
19The Ramco Cements LtdRAMCOCEM 41.3/100Mixed-negative evidence94% evidence BASING 18.6/35 Revenue 8.6% · PAT 100% · OPM change -6 pp 100% evidence 9.2/25 ROCE 6.1% · OPM 13% 100% evidence 1.5/20 P/E 112× · PEG 4.14 100% evidence 12.0/20 RS sector 11.1% · RS bench -11.1% · 1Y -15.4%0 of 10 weeks ahead 70% evidence
Exact sum: 18.6 + 9.2 + 1.5 + 12 = 41.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Sagar Cements LtdSAGCEM 41.2/100Mixed-negative evidence72% evidence ASLEEP 20.0/35 Revenue 13.4% · PAT 79.7% · OPM change -8 pp 95% evidence 5.1/25 ROCE 2% · OPM 10% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 6.1/20 RS sector -6.8% · RS bench -16.1% · 1Y -23.4%1 of 12 weeks ahead 100% evidence
Exact sum: 20 + 5.1 + 10 + 6.1 = 41.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Ambuja Cements LtdAMBUJACEM 40.3/100Mixed-negative evidence82% evidence ASLEEP 10.6/35 Revenue 7.1% · PAT -5.9% · OPM change -2 pp 95% evidence 11.0/25 ROCE 5.6% · OPM 17% 76% evidence 12.8/20 P/E 22× · PEG — 50% evidence 5.9/20 RS sector -8.6% · RS bench -17.4% · 1Y -28%0 of 12 weeks ahead 100% evidence
Exact sum: 10.6 + 11 + 12.8 + 5.9 = 40.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22BIGBLOC Construction LtdBIGBLOC 35.9/100Mixed-negative evidence72% evidence ASLEEP 18.8/35 Revenue 33.5% · PAT 11.3% · OPM change 5.6 pp 71% evidence 6.1/25 ROCE 1.9% · OPM 7.9% 95% evidence 8.5/20 P/E 379× · PEG — 15% evidence 2.5/20 RS sector -10.6% · RS bench -18.9% · 1Y -12.5%1 of 12 weeks ahead 100% evidence
Exact sum: 18.8 + 6.1 + 8.5 + 2.5 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Saurashtra Cement LtdSAURASHCEM 35.4/100Mixed-negative evidence80% evidence ASLEEP 14.5/35 Revenue 7.9% · PAT -52.1% · OPM change -3.7 pp 95% evidence 5.3/25 ROCE 2.5% · OPM 4.5% 95% evidence 9.4/20 P/E 41.9× · PEG — 15% evidence 6.2/20 RS sector -13.9% · RS bench -23% · 1Y -48.8%0 of 12 weeks ahead 100% evidence
Exact sum: 14.5 + 5.3 + 9.4 + 6.2 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Deccan Cements LtdDECCANCE 33.0/100Adverse evidence80% evidence ASLEEP 14.1/35 Revenue 39.4% · PAT -48.2% · OPM change -10.8 pp 95% evidence 7.5/25 ROCE 3.3% · OPM 7.7% 95% evidence 10.1/20 P/E 28.1× · PEG — 15% evidence 1.3/20 RS sector -20.4% · RS bench -28.7% · 1Y -48%0 of 12 weeks ahead 100% evidence
Exact sum: 14.1 + 7.5 + 10.1 + 1.3 = 33 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Shree Digvijay Cement Co. LtdSHREDIGCEM 32.1/100Adverse evidence81% evidence ASLEEP 12.1/35 Revenue 19.6% · PAT -35% · OPM change -3.5 pp 95% evidence 8.5/25 ROCE 6.4% · OPM 8.7% 95% evidence 5.5/20 P/E 59.1× · PEG — 50% evidence 6.0/20 RS sector -12.4% · RS bench -11% · 1Y -11.4%3 of 10 weeks ahead 70% evidence
Exact sum: 12.1 + 8.5 + 5.5 + 6 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Shiva Cement LtdSHIVACEM 36.5/100Thin evidence · provisional42% evidence 18.1/35 Revenue 19.7% · PAT -47.1% · OPM change 15 pp 40% evidence 5.4/25 ROCE -3% · OPM 1% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 3.0/20 RS sector -27.5% · RS bench -36.4% · 1Y -51.7%0 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 18.1 + 5.4 + 10 + 3 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is India Cements Ltd's share price today?

India Cements Ltd trades at ₹375, +1.7% over the past year. The company is valued at ₹11,630 Cr. The stock sits at 17% of its 52-week range of ₹354–₹479, −4.1% versus its 200-day average. On the tape, the price is in a downtrend, 1 weeks in. — as of 14 August 2026.

What were India Cements Ltd's latest quarterly results?

India Cements Ltd reported revenue of ₹1,019 Cr and net profit of ₹27.0 Cr for the Jun 26 quarter. Earnings per share were ₹0.87. The operating margin was 15.0%, 7.0 pp higher than a year earlier. — as of 14 August 2026.

What is India Cements Ltd's revenue?

India Cements Ltd reported revenue of ₹1,019 Cr in the Jun 26 quarter, −0.6% year on year. For the full FY26 fiscal year, revenue was ₹4,485 Cr (+8.3%). Over the last 10 years revenue compounded at −0.8% a year. — as of 14 August 2026.

What is India Cements Ltd's profit?

India Cements Ltd earned ₹27.0 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹−67.0 Cr. The operating margin ran 15.0% in the latest quarter. — as of 14 August 2026.

What is India Cements Ltd's market cap?

India Cements Ltd's market capitalisation is ₹11,630 Cr at a share price of ₹375. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.

What is India Cements Ltd's P/E ratio?

India Cements Ltd trades at a P/E of 86.2×, at the 83rd percentile of its own 10-year range, against a long-run median of 41.9×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.

Does India Cements Ltd pay a dividend?

Not in its latest year — India Cements Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 7 of its last 13 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.

Is India Cements Ltd overvalued?

On its own history, India Cements Ltd looks expensive: its P/E of 86.2× sits at the 83rd percentile of its 10-year range (long-run median 41.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.

How is India Cements Ltd performing?

India Cements Ltd is in a downtrend, 1 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 14 August 2026.

Is India Cements Ltd in an uptrend?

No — the price is in a downtrend (week 1 of stage 4), trading −4.1% versus its 200-day average and at 17% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.

Is India Cements Ltd beating the market?

Not lately — on a trailing-13-week view India Cements Ltd is currently behind the NIFTY 500 (2 weeks and counting; last ahead the week of 2026-07-31), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +456% against the NIFTY 500's +284% — ahead of the index over the full window. — as of 14 August 2026.

Will India Cements Ltd's share price go up?

This page publishes no price forecast for India Cements Ltd. What it measures instead: the share price is ₹375, the price is in a downtrend 1 weeks in. Its P/E of 86.2× sits at the 83rd percentile of its own 10-year range. — as of 14 August 2026.

Who owns India Cements Ltd?

Promoters hold 75.0% of India Cements Ltd, foreign institutions 3.4%, domestic institutions 12.6% and the public 9.0% (latest quarter). The biggest move on the register over the last two years: Promoters added 46.6 points over 8 quarters. — as of 14 August 2026.

Does India Cements Ltd have too much debt?

No — India Cements Ltd's debt-to-equity is 0.13, and operating profit covers the interest bill 4×. FY26 borrowings were ₹1,305 Cr against equity of ₹10,124 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.

What is India Cements Ltd's capex?

India Cements Ltd spent ₹5,173 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹15.0 Cr, with ₹344 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.

What is India Cements Ltd's cash flow?

India Cements Ltd consumed ₹27.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−42.0 Cr). Reported profit that year was ₹−67.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 14 August 2026.

Is India Cements Ltd's profit real cash?

Yes — over the last 3 fiscal years, 539% of India Cements Ltd's reported profit arrived as operating cash. Though the latest year ran at 40% — the trend is the thing to watch. In FY26, operating cash was ₹−27.0 Cr against reported profit of ₹−67.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 14 August 2026.

Where is India Cements Ltd in its business cycle?

India Cements Ltd's FY26 operating margin was 9.0%, against a 13-year band of −8.0%–18.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 15.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.

What could break the India Cements Ltd story?

Biggest watch item: the P/E sits at the 83rd percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.

Is India Cements Ltd a stock worth studying right now?

This is not investment advice. The machine read: India Cements Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI